The Impact of COVID-19 on Intravitreal Injection Compliance-Reference-Cited by-同舟云学术

The Impact of COVID-19 on Intravitreal Injection Compliance

Published:2020-10-28 Issue:12 Volume:2 Page:2546-2549
ISSN:2523-8973
Container-title:SN Comprehensive Clinical Medicine
language:en
Short-container-title:SN Compr. Clin. Med.

Author:

Wasser Lauren M.^ORCID,Weill Yishay^ORCID,Brosh Koby,Magal Itay,Potter Michael,Strassman Israel,Gelman Evgeny,Koslowsky Meni,Zadok David,Hanhart Joel^ORCID

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/content/pdf/10.1007/s42399-020-00614-4.pdf

Reference34 articles.

1. Parikh R, Pirakitikulr N, Chhablani J, Sakurada Y, Singh RP, Modi YS. A multinational comparison of anti-vascular endothelial growth factor use: the United States, the United Kingdom, and Asia-Pacific, (in eng). Ophthalmol Retina. 2019;3(1):16–26. https://doi.org/10.1016/j.oret.2018.08.002.

2. Haller JA. Current anti-vascular endothelial growth factor dosing regimens: benefits and burden, (in eng). Ophthalmology. 2013;120(5 Suppl):S3–7. https://doi.org/10.1016/j.ophtha.2013.01.057.

3. Angermann R, et al. Treatment compliance and adherence among patients with diabetic retinopathy and age-related macular degeneration treated by anti-vascular endothelial growth factor under universal health coverage, (in eng). Graefes Arch Clin Exp Ophthalmol. 2019;257(10):2119–25. https://doi.org/10.1007/s00417-019-04414-y.

4. Sun JK, Wang PW, Taylor S, Haskova Z. Durability of diabetic retinopathy improvement with as-needed ranibizumab: open-label extension of RIDE and RISE studies, (in eng). Ophthalmology. 2019;126(5):712–20. https://doi.org/10.1016/j.ophtha.2018.10.041.

5. Campochiaro PA, et al. Monthly versus as-needed ranibizumab injections in patients with retinal vein occlusion: the SHORE study, (in eng). Ophthalmology. 2014;121(12):2432–42. https://doi.org/10.1016/j.ophtha.2014.06.011.

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relative yield of retinal imaging versus clinical exam in following neovascular exudative age related macular degeneration;International Ophthalmology;2024-03-11

2. Anatomical and Functional Outcomes with Prompt versus Delayed Initiation of Anti-VEGF in Exudative Age-Related Macular Degeneration;Journal of Clinical Medicine;2023-12-25

3. Patient adherence to therapy after switch to aflibercept from bevacizumab or ranibizumab for treatment-refractory neovascular age-related macular degeneration;Indian Journal of Ophthalmology;2023-12-22

4. Risk Stratification for Diabetic Retinopathy Screening Order Using Deep Learning: A Multicenter Prospective Study;Translational Vision Science & Technology;2023-12-11

5. Examining Global Crises: Extracting Insights From the COVID-19 Pandemic and Natural Disasters to Develop a Robust Emergency Diabetic Retinopathy Strategy for Puerto Rico;Cureus;2023-10-15